Kim Hyong, the chief medical officer at Alignment Healthcare Inc. (NASDAQ: ALHC), has executed a significant divestment of company shares. On June 12, 2026, the executive sold 35,951 shares of common stock. The transaction, valued at approximately $713,947, was facilitated under a Rule 10b5-1 trading plan that was initially adopted on March 13, 2026. This pre-arranged framework is designed to automate trading activities, ensuring compliance with securities regulations while allowing executives to manage their equity holdings systematically.
The shares were liquidated at a weighted-average price of $19.8589 per share. Individual sales within this block occurred at prices ranging from $19.57 to $20.24. The timing of this sale is particularly notable given the recent performance of the stock. Over the past week, Alignment Healthcare's shares experienced a substantial 28.86% surge, culminating in a current price of $19.78. This rapid appreciation raises questions about the valuation context surrounding the executive's decision to sell.
Following this transaction, Kim Hyong continues to hold a direct stake in the company, with 331,750 shares remaining in their portfolio. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value estimate. Investors can explore more valuation insights on the platform’s most overvalued stocks list. InvestingPro offers 12 additional exclusive tips for ALHC, plus comprehensive Pro Research Reports covering over 1,400 US equities.
In other recent news, Alignment Healthcare reported its first-quarter 2026 earnings, surpassing analysts’ expectations. The company achieved earnings per share of $0.05, significantly higher than the projected $0.01. Revenue also exceeded forecasts, reaching $1.23 billion compared to the anticipated $1.22 billion. KeyBanc reiterated its Overweight rating on Alignment Healthcare with a price target of $28, noting the stock’s volatility following the first-quarter report. Additionally, there have been leadership changes within the company. Founder and CEO John Kao will now also serve as Chairman of the Board. Joseph Konowiecki, the previous Board Chairman, will take on the roles of Vice Chairman and Executive Vice President of Corporate Affairs. In his new position, Konowiecki will manage Human Resources, Legal, and Communications.
Alignment Healthcare LLCFollowAnalyze ALHCIncluded in our AI-picked strategies·Review strategies19.78▲+0.03(+0.15%)Closed·15:59:59·USD19.98▲+0.20(+1.01%)After Hours·17:42:421D1W1M6M1Y5YMaxCreated with Highcharts 11.4.814:0015:0016:0017:0018:0019:001919.2519.519.75Analyze ALHCThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.Spot the trade on ALHC before it happensMost traders know the market. The hard part is the moment — which stock, right now, at what price.
Chart analysis handles that.
Our Vision AI scans your charts, spots the pattern before it plays out, and hands you the complete setup: entry, exit, done in under 60 seconds. Investors are already reporting a high accuracy rate, even on penny stocks.Flash Sale - Price Goes Up Soon